Skip to content

A study to evaluate the effect of amoxicillin/clavulanate on the pharmacokinetics of valproic acid in healthy adult volunteers

An open-label study to evaluate the effect of amoxicillin/clavulanate on the pharmacokinetics of valproic acid in healthy adult volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CRIS
Registry ID
KCT0001165
Enrollment
16
Registered
2014-07-15
Start date
2014-05-30
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : At Period I(1d), subjects are administered a valproic acid 500 mg tablet orally. From Period II(6d),subjects are administered an amoxicillin/clavulanate 500/125 mg tablet, 3 times daily, for 7

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Adult male aged 19 to 55 years at screening 2) A body mss index between 19 and 27 kg/m2 at screening 3) A subject who is able to understand the study, and to provide written informed consent voluntarily after being fully informed of the study objectives, procedures and study drug 4) A subejct who is able to participate the whole study period

Exclusion criteria

Exclusion criteria: 1) A subject who has the medical history of or has the clinically significant hepatobiliary, renal, gastrointestinal, respiratory, musculoskeletal, endocrinal, hemato-oncologic, or cardiovascular disease 2) A subject who has systolic blood pressure 1.5 times of upper normal limit 11) A subject who has the glomerular filtration rate (GFR) calculated by plasma creatinine values < lower normal limit 12) A subject who is inadequate for the clinical trial by the investigator’s decision

Design outcomes

Primary

MeasureTime frame
Cmax, AUClast of valproic acid

Secondary

MeasureTime frame
tmax, t1/2, AUCinf of valproic acid

Countries

Korea, Republic of

Contacts

Public ContactSoo-Yun Lee

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026